EMAIL THIS PAGE TO A FRIEND

The international journal of neuropsychopharmacology

Corticosterone treatment during adolescence induces down-regulation of reelin and NMDA receptor subunit GLUN2C expression only in male mice: implications for schizophrenia.


PMID 24556017

Abstract

Stress exposure during adolescence/early adulthood has been shown to increase the risk for psychiatric disorders such as schizophrenia. Reelin plays an essential role in brain development and its levels are decreased in schizophrenia. However, the relationship between stress exposure and reelin expression remains unclear. We therefore treated adolescent reelin heteroyzogous mice (HRM) and wild-type (WT) littermates with the stress hormone, corticosterone (CORT) in their drinking water (25xa0mg/l) for 3 wk. In adulthood, we measured levels of full-length (FL) reelin and the N-R6 and N-R2 cleavage fragments in the frontal cortex (FC) and dorsal (DH) and ventral (VH) hippocampus. As expected, levels of all reelin forms were approximately 50% lower in HRMs compared to WT. In male mice, CORT treatment significantly decreased FL and N-R2 expression in the FC and N-R2 and N-R6 levels in the DH. This reelin down-regulation was accompanied by significant reductions in downstream N-methyl-D-aspartate (NMDA) GluN2C subunit levels. There were no effects of CORT treatment in the VH of either of the sexes and only subtle changes in female DH. CORT-induced reelin and GluN2C down-regulation in males was not associated with changes in two GABAergic neuron markers, GAD67 and parvalbumin, or glucocorticoids receptors (GR). These results show that CORT treatment causes long-lasting and selective reductions of reelin form levels in male FC and DH accompanied by changes in NMDAR subunit composition. This sex-specific reelin down-regulation in regions implicated in schizophrenia could be involved in the effects of stress in this disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

MAB1572
Anti-Parvalbumin Antibody, 100 µL, Anti-Parvalbumin Antibody is an antibody against Parvalbumin for use in IC, IH(P) & WB.
MAB5364
Anti-Reelin Antibody, a.a. 164-496 mreelin, clone G10, 100 µg, Detect Reelin using this Anti-Reelin Antibody, a.a. 164-496 mreelin, clone G10 validated for use in IH & WB.
SAB2502009
Anti-GAD1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4300642
Anti-GAD1 antibody produced in rabbit, affinity isolated antibody
HPA058412
Anti-GAD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107053
Anti-GAD1 antibody produced in rabbit, affinity isolated antibody
SAB2105927
Anti-GAD1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2100974
Anti-GRIN2A antibody produced in rabbit, affinity isolated antibody
SAB1405895
Anti-GRIN2C antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1410576
Anti-GRIN2C antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2500752
Anti-Parvalbumin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA048536
Anti-PVALB antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
R4904 Anti-Reelin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0002571M2
Monoclonal Anti-GAD1 antibody produced in mouse, clone 5E11, purified immunoglobulin, buffered aqueous solution
SAB1403849
Monoclonal Anti-GAD1 antibody produced in mouse, clone 1D12, ascites fluid
G5419
Monoclonal Anti-Glutamic Acid Decarboxylase 67 (GAD67) antibody produced in mouse, clone K-87, purified antibody
SAB4200545
Monoclonal Anti-Parvalbumin antibody produced in mouse, ~1.0 mg/mL, clone PARV-19, purified immunoglobulin